(Q44596853)

4 December 2017

A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis (English)

1 reference

4 December 2017

0 references

0 references

5

1 reference

Naiara Rodríguez-Ezpeleta

4 December 2017

13

1 reference

4 December 2017

14

1 reference

4 December 2017

A Alcina

8

0 references

Elena Urcelay

object named as

E Urcelay

6

0 references

Koen Vandenbroeck

object named as

K Vandenbroeck

1

0 references

Stacy J. Caillier

15

object named as

S Caillier

1 reference

4 December 2017

18

J R Oksenberg

1 reference

4 December 2017

17

X Montalban

1 reference

4 December 2017

J Alvarez

2

1 reference

4 December 2017

B Swaminathan

3

1 reference

4 December 2017

I Alloza

4

1 reference

4 December 2017

M Comabella

7

1 reference

4 December 2017

M Fedetz

9

1 reference

4 December 2017

M A Ortiz

10

1 reference

4 December 2017

G Izquierdo

11

1 reference

4 December 2017

O Fernandez

12

1 reference

4 December 2017

R Arroyo

16

1 reference

4 December 2017

A Antigüedad

19

1 reference

4 December 2017

A Aransay

20

1 reference

4 December 2017

30 June 2011

1 reference

4 December 2017

8

1 reference

inferred from page(s)

published in

Genes and Immunity

1 reference

4 December 2017

13

1 reference

4 December 2017

1

1 reference

4 December 2017

21-28

1 reference

https://scigraph.springernature.com/pub.10.1038/gene.2011.44

4 December 2017

0 references

cites work

Multiple sclerosis genetics--is the glass half full, or half empty?

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

Risk alleles for multiple sclerosis identified by a genomewide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

Glutamate-mediated glial injury: mechanisms and clinical importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

The expanding genetic overlap between multiple sclerosis and type I diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

Genome-wide scan of 500,000 single-nucleotide polymorphisms among responders and nonresponders to interferon beta therapy in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

SOCS1 and SOCS3 in the control of CNS immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

Regulation of signal transducer and activator of transcription and suppressor of cytokine-signaling gene expression in the brain of mice with astrocyte-targeted production of interleukin-12 or experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

Treatment of mice with the suppressor of cytokine signaling-1 mimetic peptide, tyrosine kinase inhibitor peptide, prevents development of the acute form of experimental allergic encephalomyelitis and induces stable remission in the chronic relapsing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

Functional SOCS1 polymorphisms are associated with variation in obesity in whites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

Coordinate expression of the PRM1, PRM2, and TNP2 multigene locus in human testis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

No gene is an island: the flip-flop phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

Validation of IRF5 as multiple sclerosis risk gene: putative role in interferon beta therapy and human herpes virus-6 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

PLINK: a tool set for whole-genome association and population-based linkage analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

Haploview: analysis and visualization of LD and haplotype maps

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

Variation in interleukin 7 receptor α chain (IL7R) influences risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

Functional Polymorphism in theSuppressor of Cytokine Signaling 1Gene Associated with Adult Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

IL-22RA2 Associates with Multiple Sclerosis and Macrophage Effector Mechanisms in Experimental Neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

IL7RA polymorphisms and susceptibility to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

7 January 2021

Differential expression of SOCS1 in macrophages in relapsing-remitting and chronic EAE and its role in disease severity

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

7 January 2021

Differential expression of suppressors of cytokine signaling-1 and -3 and related cytokines in central nervous system during remitting versus non-remitting forms of experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

7 January 2021

Interferon-gamma-oligodendrocyte interactions in the regulation of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

7 January 2021

Loss of suppressor of cytokine signaling 1 in helper T cells leads to defective Th17 differentiation by enhancing antagonistic effects of IFN-gamma on STAT3 and Smads

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.44

7 January 2021

Identifiers

DOI

10.1038/GENE.2011.44

1 reference

4 December 2017

1 reference